Literature DB >> 10643009

Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone.

M H Zheng1, P Siu, J M Papadimitriou, D J Wood, A R Murch.   

Abstract

Giant cell tumor of bone (GCT) is regarded as a rare primary bone neoplasm derived from stromal cells, which have the ability to recruit and harbor macrophage and multinucleated osteoclast-like giant cells. Despite being often considered benign, GCT is a problematic neoplasm in that it is aggressive, unpredictable and difficult to treat effectively. Cytogenetically GCT is characterised by a high frequency of telomeric fusion, a process which has been implicated in the production of chromosome instability and tumorigenesis. To extend our knowledge of the significance of telomere association in GCT, the cytogenetics of cell lines derived from spindle-shaped stromal-like mononuclear cells (the tumor cells) of GCT was investigated. Cell lines from three different patients showed telomeric association in all passages. The rate of telomeric association varied from line to line and from passage to passage, but there was no particular pattern to the variations. Many other cytogenetic abnormalities were seen as well as telomeric association, but these were rarely clonal. The nature of most of the other abnormalities seen, such as deleted chromosomes and chromosomes with additional unidentifiable material, was consistent with their being formed as a result of breakage of the dicentric fused chromosomes at a telophase. Chromosomes 13, 14 and 21 were most commonly involved in telomeric fusion. It appears that telomeric association persists in long-term cultures of GCT and is responsible for the accumulation of other associated cytogenetic aberrations. Telomeric reduction and telomerase activity may act as oncogenic events, promoting and sustaining the transformed GCT phenotype.

Entities:  

Mesh:

Year:  1999        PMID: 10643009     DOI: 10.1080/003130299104756

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  10 in total

Review 1.  Giant cell tumor of bone.

Authors:  Alan W Yasko
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

2.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour.

Authors:  Juan Luis García; Cristina Robledo; E Lumbreras; Teresa Flores; Luis Ramos; Jesús M Hernández
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

4.  Chromosomal translocation and segmental duplication in Cryptococcus neoformans.

Authors:  James A Fraser; Johnny C Huang; Read Pukkila-Worley; J Andrew Alspaugh; Thomas G Mitchell; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2005-02

5.  Histogenetic characterization of giant cell tumor of bone.

Authors:  Manuela Salerno; Sofia Avnet; Marco Alberghini; Armando Giunti; Nicola Baldini
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

6.  Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Authors:  Teresa Morgan; Gerald J Atkins; Melanie K Trivett; Sandra A Johnson; Maya Kansara; Stephen L Schlicht; John L Slavin; Paul Simmons; Ian Dickinson; Gerald Powell; Peter F M Choong; Andrew J Holloway; David M Thomas
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

7.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 8.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

9.  Clinical and cytogenetic aspects of giant cell tumor of the sternum.

Authors:  Edgard Eduard Engel; Marcello Henrique Nogueira-Barbosa; Maurício Eiji de Almeida Santos Yamashita; Federico Enrique Garcia Cipriano; Elvis Terci Valera; Maria Sol Brassesco
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  The role of dicentric chromosome formation and secondary centromere deletion in the evolution of myeloid malignancy.

Authors:  Ruth N Mackinnon; Lynda J Campbell
Journal:  Genet Res Int       Date:  2011-09-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.